Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring.
about
Minimally invasive surgical therapies for atrial fibrillation.Current and emerging indications for implantable cardiac monitors.The Reveal LINQ insertable cardiac monitor.Holter Monitoring and Loop Recorders: From Research to Clinical Practice.Current rare indications and future directions for implantable loop recorders.Pulmonary vein isolation with concomitant renal artery denervation is associated with reduction in both arterial blood pressure and atrial fibrillation burden: Data from implantable cardiac monitor.Atrial fibrillation and stroke: the evolving role of rhythm controlPulmonary vein isolation alone and combined with renal sympathetic denervation in chronic kidney disease patients with refractory atrial fibrillationRenin Angiotenin Blocker Pre-treatment and Recurrence After Pulmonary Vein Isolation in Patients with Paroxysmal and Persistent Atrial FibrillationLoop Recorder Detected High Rate of Atrial Fibrillation Recurrence after a Single Balloon- or Basket-Based Ablation of Paroxysmal Atrial Fibrillation: Results of the MACPAF Study.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designIncidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study.Rhythm Control and Its Relation to Symptoms during the First Two Years after Radiofrequency Ablation for Atrial Fibrillation.Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial.Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.Relevance of Monitoring Atrial Fibrillation in Clinical Practice.Safety Profile of a Miniaturized Insertable Cardiac Monitor: Results from Two Prospective Trials.The Role of Continuous Monitoring in Atrial Fibrillation Management.Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Implantable loop recorders in the real world: a study of two Canadian centers.Results of the first investigator-initiated randomized clinical trial of nMARQTM, PVACTM, and thoracoscopic ablation for paroxysmal atrial fibrillation.Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.Long-term outcomes after surgical ablation for atrial fibrillation in patients with continuous heart rhythm monitoring devices.Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation.Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.Continuous Cardiac Monitoring around Atrial Fibrillation Ablation: Insights on Clinical Classifications and End Points.Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation.The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients.Reduction of Arrhythmia Burden and Reverse Remodeling in Patients with Persistent Atrial Fibrillation and Severe Atrial Remodeling: The Benefits of Hybrid Ablation.Improvement of Atrial and Ventricular Remodeling with Low Atrial Fibrillation Burden after Hybrid Ablation of Persistent Atrial Fibrillation.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
P2860
Q30466830-70045DAD-4895-45A5-87E3-F9AFA20E335AQ33161241-3C5475FF-9A8E-4152-A73D-F44943D6CABAQ33164661-0A56A822-9835-4520-B153-279982D364CFQ33167676-649B28AB-29C1-4154-8603-03D8CF908F78Q33167930-8A9ABD2A-C4EB-4883-8AFB-6507F23E6CF4Q36351044-31136AB8-FA7E-4373-BE4B-855860D03AC7Q36836836-035B0CB7-B51D-498F-94D4-9924A31751D8Q37480869-8FBC24CA-9F99-40E2-BEE0-7825FACFDFAAQ37495706-174C061D-7532-4E94-BF7D-5CBF0DF0D3B7Q37637902-904C26DE-076B-4879-9779-8DC81F767911Q37989837-264C8F50-4E84-40B3-8977-D59ED02C5D52Q38382602-609A6E2E-52E7-4FD3-A168-B0259EE02C15Q38390127-BFE7E2A4-3A0A-4C25-AD52-3B215C1161ACQ38408829-ECF047C6-4268-402D-8C53-FF3454B5D767Q38790508-3F953F6F-1165-4494-A4B7-CEF3D22CBCAAQ40033486-F3692FD8-C844-465D-AB39-24AA2FE35F29Q40494027-89BBD589-736E-41D7-90AB-64840BE11AC9Q43090313-0DB6D3BF-DD3E-4AFF-971A-7F8F46A134A4Q43932170-F106EFE4-9330-42A5-AFD6-C27FC73C9A05Q45059153-796C389F-30B0-4A30-8B67-55AE8C5DD22EQ46658026-F98065DD-DE37-48B2-88D6-8B52DD98CFD1Q47227449-D4C3566E-F68C-4323-91A2-DE4080333023Q47391223-8F5D481F-BA48-41B1-B8AB-6ADE2D9D096CQ49630118-A22919A8-4AFE-43C6-98F0-2071539B92E4Q50241164-FB92E1D8-130B-4462-8F57-AFE379A52D44Q50687220-D7F88663-8B82-4609-A754-9A560F48E601Q50868122-8E997352-B0CF-436F-ACA0-AF642BBBB581Q51317069-268E8401-D68C-4962-AF44-782FE45C873AQ51339645-7EDE10FE-77F7-4037-8E34-90E5E51DA118Q51781461-E8284EF8-FD23-4D96-8F1A-872FC8E23BAAQ53644788-048648A5-2AB9-4F51-A434-8E6A7D79C118Q53651467-BA771363-4168-4517-AFF3-6F03094A35D2Q55263071-E71E497C-18F7-47BC-AD26-748191D40C15
P2860
Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@en
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@nl
type
label
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@en
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@nl
prefLabel
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@en
Ablation of paroxysmal and per ...... nuous subcutaneous monitoring.
@nl
P2093
P50
P1476
Ablation of paroxysmal and per ...... inuous subcutaneous monitoring
@en
P2093
Alex Turov
Giorgio Corbucci
Natalya Shirokova
Sergey Artyomenko
P304
P356
10.1111/J.1540-8167.2010.01923.X
P577
2010-10-11T00:00:00Z